Lithium Side Effects and Monitoring
Lithium therapy requires comprehensive baseline and ongoing laboratory monitoring every 3-6 months, including renal function (BUN, creatinine, urinalysis), thyroid function tests, serum calcium, and complete blood counts, with side effects ranging from common benign symptoms like tremor and polyuria to serious dose-dependent toxicity above 1.5 mEq/L. 1, 2
Common Side Effects (Generally Benign)
The most frequently encountered side effects include:
- Fine hand tremor - occurs commonly and may persist throughout treatment
- Polyuria and mild thirst - very common, may resemble diabetes insipidus
- Mild nausea and general discomfort - typically transient during initial therapy
- Gastrointestinal symptoms - nausea, vomiting, diarrhea 2
These effects are typically more of an inconvenience than disabling and usually subside with continued treatment or temporary dose reduction 2. However, they can contribute to nonadherence 3.
More Problematic Side Effects
Weight gain and cognitive impairment tend to be more distressing to patients, more difficult to manage, and more likely to cause treatment discontinuation 3. These require proactive discussion and management strategies.
Organ System Effects Requiring Monitoring
Renal Effects
The most important long-term concern is interstitial nephropathy, typically occurring after 10-20 years of administration 4. Most lithium-associated renal effects are relatively mild, but a small percentage of patients will show progressive renal impairment requiring discontinuation 3. This necessitates regular monitoring of BUN, creatinine, and urinalysis every 3-6 months 1.
Thyroid Effects
Lithium-induced hypothyroidism is relatively common but easily diagnosed and treated 3. Euthyroid goiter and/or hypothyroidism with lower T3 and T4 may occur, though paradoxically rare cases of hyperthyroidism have been reported 2. Thyroid function tests should be monitored every 3-6 months 1.
Parathyroid Effects
Hyperparathyroidism is a more recently recognized phenomenon requiring baseline and periodic serum calcium monitoring 1, 3.
Toxicity: The Critical Concern
Lithium toxicity likelihood increases dramatically with serum levels above 1.5 mEq/L, though sensitive patients may exhibit toxic signs below this threshold 2.
Early Warning Signs (levels <2 mEq/L):
- Diarrhea
- Vomiting
- Drowsiness
- Muscular weakness
- Lack of coordination 2
Higher Level Toxicity:
- Giddiness, ataxia
- Blurred vision, tinnitus
- Large output of dilute urine
- Levels above 3 mEq/L produce complex multi-organ toxicity 2
Serum lithium levels should not exceed 2 mEq/L during acute treatment 2.
Neurological Side Effects
Beyond toxicity, lithium can cause:
- Tremor and muscle hyperirritability (fasciculations, twitching)
- Ataxia, choreo-athetotic movements
- Blackout spells, epileptiform seizures
- Slurred speech, dizziness, vertigo
- Somnolence, confusion, stupor, coma in severe cases
- Pseudotumor cerebri (increased intracranial pressure) - if undetected, may result in blindness; lithium should be discontinued if this occurs 2
Cardiovascular Effects
Cardiac arrhythmias, hypotension, peripheral circulatory collapse, and sinus node dysfunction with severe bradycardia (potentially causing syncope) may occur 2.
Dermatologic Effects
Drying and thinning of hair, alopecia, chronic folliculitis, and exacerbation of psoriasis are documented 2.
Required Baseline Assessment
Before initiating lithium 1:
- Complete blood cell counts
- Thyroid function tests
- Urinalysis
- BUN, creatinine, serum calcium
- Pregnancy test in female adolescents
- Body mass index and blood pressure (for comprehensive metabolic monitoring)
Ongoing Monitoring Protocol
Once stable lithium dose is achieved 1:
- Lithium levels every 3-6 months
- Renal function (BUN, creatinine) every 3-6 months
- Thyroid function every 3-6 months
- Urinalysis every 3-6 months
Critical caveat: Periodic monitoring does not ensure abnormalities will be readily identified. Patients and families must be educated about presenting symptoms of potential adverse effects 1.
Risk Factors for Toxicity
Lithium toxicity risk is substantially elevated in patients with 2, 5:
- Significant renal or cardiovascular disease
- Severe debilitation or dehydration
- Sodium depletion
- Concurrent diuretic use
- Drug interactions (particularly NSAIDs, ACE inhibitors)
- Advanced age
- Environmental factors (heat, dehydration)
Lithium should generally not be given to these patients unless the psychiatric indication is life-threatening 2.
Management Strategies for Side Effects
For common side effects like tremor, polyuria, and GI symptoms 3:
- Adjust timing of lithium dose
- Minimize lithium levels within the therapeutic range (aim for lower end)
- Consider side effect antidotes in specific situations
- Ensure adequate hydration and stable sodium intake
Discontinuation Considerations
Lithium should be tapered gradually to avoid withdrawal symptoms and rebound worsening of mania 6, 5. Abrupt discontinuation carries significant relapse risk. When discontinuing in patients on multiple medications, lithium's prophylactic efficacy and long-term safety profile should be weighed against other agents 6.